ZyVersa Therapeutics Inc. (ZVSA) — Financial Flexibility Index
ZyVersa Therapeutics Inc. (ZVSA) has a Financial Flexibility Index of -110.21x as of September 2025. Free cash flow of $-1.41 Billion (operating CF $-1.41 Billion minus capex $0.00) represents -110% of total liabilities ($12.77 Million). Check ZyVersa Therapeutics Inc. strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
ZyVersa Therapeutics Inc. Financial Flexibility Index (2020–2024)
Historical Financial Flexibility Index trend for ZyVersa Therapeutics Inc. across 5 annual periods. See ZVSA current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for ZyVersa Therapeutics Inc. (2020–2024)
Year-by-year free cash flow to debt coverage for ZyVersa Therapeutics Inc.. For the full company profile including market capitalisation, see ZVSA stock market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.63x | $-7.56 Million | $-7.56 Million | $12.08 Million | ▲ +20.8% |
| 2023 | -0.79x | $-8.72 Million | $-8.72 Million | $11.04 Million | ▼ -199.1% |
| 2022 | -0.26x | $-4.89 Million | $-4.89 Million | $18.51 Million | ▲ +29.1% |
| 2021 | -0.37x | $-5.08 Million | $-5.08 Million | $13.63 Million | ▲ +32.6% |
| 2020 | -0.55x | $-5.11 Million | $-5.11 Million | $9.24 Million | — |